Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 30: 1322-1326, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampson, E. J.
Right arrow Articles by Fast, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampson, E. J.
Right arrow Articles by Fast, D. M.

Clinical Chemistry, Vol 30, 1322-1326, Copyright © 1984 by American Association for Clinical Chemistry

Multivariate examination of response surfaces around the reaction conditions for the Scandinavian Society's recommended method for creatine kinase determinations

EJ Sampson, VS Whitner, M Ali and DM Fast

We examined the reaction surfaces around five variables (imidazole, ADP, creatine phosphate, magnesium, and pH) in the Scandinavian method for determining creatine kinase, using factorial experimentation (five level, five factor) at reaction temperatures of 30 and 37 degrees C. Theoretical response surfaces were computed by fitting a quadratic polynomial equation to the experimental data by least-squares regression. Essentially no differences were apparent in the theoretical curves among the five specimens we analyzed, or between reaction temperatures. Our response-surface data showed the following: for pH and imidazole, activity optima in the region of the Scandinavian conditions; for creatine phosphate, a broad plateau over the concentration range investigated (10 to 50 mmol/L); and for magnesium and ADP, gently increasing contours with maximal creatine kinase activity at concentrations greater than those investigated in our study (magnesium 15 mmol/L, ADP 3.5 mmol/L).




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.